Merck flies back to New Jersey after a week of oncology data and investor conferences

Merck flew from Fla-Net Airport in Florida back to its home base at Morristown Municipal Airport in New Jersey on Monday, June 8, 2026, a 22-minute hop in its Gulfstream G650ER, tail N822MK, that stayed under 3,700 feet.

The return trip came the same week the company wrapped up a busy stretch of high-stakes investor events. On June 4, Dr. Marjorie Green, head of oncology global clinical development, presented at the Jefferies Global Healthcare Conference, where she discussed recent Phase III data from the OptiTROP-Lung05 trial and updated KEYNOTE-522 results from the ASCO annual meeting, per a Seeking Alpha transcript. On June 9, CEO Robert Davis and R&D chief Dr. Dean Y. Li are scheduled to speak at the Goldman Sachs 47th Annual Global Healthcare Conference, as announced on Merck.com, a session investors are watching for pipeline specifics beyond the Keytruda story.

The company had previously flown the G650ER from Morristown to an area near Springfield, Massachusetts on June 2, likely onward to Chicago for the ASCO meeting, which ran May 29 through June 2 and included a June 1 evening investor event. With a two-aircraft fleet and recurring destinations like Washington Dulles and London Heathrow tied to regulatory and global business, this brief hop was simply a return to base after a week of talking about science and money.